"We already know that the over-expression or mutation of molecules known as NIK and TRAF3 in B cells is associated with human multiple myeloma," said Professor Mackay.

“我们已经知道，在B细胞过度表达或突变的NIK和TRAF3分子是与人类多发性骨髓瘤相关，”麦凯教授说。

youdao

An initial human test of the combo--chemotherapy drug idarubicin and Millennium Pharmaceuticals' multiple myeloma drug Velcade--is under way at the University of Kentucky.

FORBES: On The Cover/Top Stories